Upgrades
- Shopify (SHOP) upgraded by TD Cowen from Hold to Buy
- Fastly (FSLY) upgraded by William Blair from Market Perform to Outperform
- Shopify (SHOP) upgraded by Mizuho from Neutral to Outperform
- Oscar Health (OSCR) upgraded by Raymond James from Market Perform to Outperform
- Sandoz (SDZNY) upgraded by Jefferies from Hold to Buy
- LuxExperience (LUXE) upgraded by JPMorgan from Neutral to Overweight
- Revenio Group (REVXF) upgraded by SEB Equities from Hold to Buy
- Novo Nordisk (NVO) upgraded by Jefferies from Underperform to Hold
- Ferrari (RACE) upgraded by Citi from Sell to Neutral
- MercadoLibre (MELI) upgraded by JPMorgan from Neutral to Overweight
- Pegasystems (PEGA) upgraded by Barclays from Equal Weight to Overweight
- BorgWarner (BWA) upgraded by Deutsche Bank from Hold to Buy
Put $1,000 into this stock now [Not NVDA] [sponsor]
The legendary stockpicker who built one of Wall Street's most popular buying indicators just announced the #1 stock to buy for 2026. His last recommendations shot up 100% and 160%. Now for a limited time, he's sharing this new recommendation live on-camera, completely free of charge. It's not NVDA, AMZN, TSLA, or any stock you'd likely recognize. Click here for the name and ticker.
The legendary stockpicker who built one of Wall Street's most popular buying indicators just announced the #1 stock to buy for 2026. His last recommendations shot up 100% and 160%. Now for a limited time, he's sharing this new recommendation live on-camera, completely free of charge. It's not NVDA, AMZN, TSLA, or any stock you'd likely recognize. Click here for the name and ticker.
Downgrades
- Strattec Security (STRT) downgraded by Freedom Capital from Buy to Hold
- Vertex (VERX) downgraded by Jefferies from Buy to Hold
- BP (BP) downgraded by HSBC from Hold to Reduce
- BP (BP) downgraded by BNP Paribas from Outperform to Neutral
- Inspire Medical (INSP) downgraded by Baird from Outperform to Neutral
- Valvoline (VVV) downgraded by JPMorgan from Neutral to Underweight
- Inspire Medical (INSP) downgraded by Wells Fargo from Overweight to Equal Weight
- Pfizer (PFE) downgraded by Daiwa from Outperform to Neutral
- Rollins (ROL) downgraded by Wells Fargo from Overweight to Equal Weight
- Arcus Biosciences (RCUS) downgraded by Wells Fargo from Overweight to Equal Weight
- Rigetti Computing (RGTI) downgraded by TD Cowen from Buy to Hold
- Humana (HUM) downgraded by RBC Capital from Outperform to Sector Perform
History-Making Stocks Rarely Make Headlines. [sponsor]
While Nvidia makes all the headlines, this little-known company is already beginning to surpass Nvidia's stock gains this year as data center growth surges. I believe this stock could soar in the next 12-24 months, potentially leaving Nvidia in the dust. I want to give you the name, ticker and my full analysis today – because I know you certainly won't hear about this stock in the mainstream financial media. Click here to get all the details...
While Nvidia makes all the headlines, this little-known company is already beginning to surpass Nvidia's stock gains this year as data center growth surges. I believe this stock could soar in the next 12-24 months, potentially leaving Nvidia in the dust. I want to give you the name, ticker and my full analysis today – because I know you certainly won't hear about this stock in the mainstream financial media. Click here to get all the details...
Upgrades & Downgrades provided by The Fly at http://www.thefly.com. The Fly is a leading digital publisher of real-time financial news. Our financial market experts understand that news impacting stock prices can originate from anywhere, at any time. The Fly team scours all sources of company news, from mainstream to cutting-edge, then filters out the noise to deliver short-form stories consisting of only market moving content. Become an informed investor. Try all of The Fly’s services FREE for 14 days by clicking here.